Covid-19 Vaccination During Pregnancy in France: a Descriptive Study of Uptake Using the National Healthcare data

Elise Quentin1, Ismaïl Ahmed1, Chi-Hong Duong1

  • 1Université Paris-Saclay, UVSQ, Inserm, CESP, High Dimensional Biostatistics for Drug Safety and Genomics, Villejuif, France..

Vaccine
|May 21, 2025
PubMed

Insights

COVID-19 vaccine uptake during pregnancy in France was lower than in the general population, with only 26% of pregnant women receiving a vaccine during gestation. Targeted campaigns are needed to improve vaccination coverage in pregnant individuals.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Pregnant women and fetuses face elevated risks from SARS-CoV-2 infection.
  • Understanding COVID-19 vaccine uptake patterns during pregnancy is crucial for maternal and fetal health.
  • France initiated COVID-19 vaccination in late 2020, making timely data collection essential.

Purpose of the Study:

  • To assess COVID-19 vaccine uptake among pregnant women in France.
  • To analyze vaccination patterns based on socio-demographic factors and calendar time.
  • To examine vaccine uptake across different pregnancy stages and in relation to SARS-CoV-2 infection.

Main Methods:

  • Utilized national healthcare database records for women ending pregnancy between December 2020 and December 2022.
  • Linked vaccination and SARS-CoV-2 infection data.
  • Calculated weekly vaccination rates by pregnancy phase, considering periods of ineligibility post-infection.

Main Results:

  • Overall vaccine uptake (at least one dose) was 75% in 2021-2022, lower than the general population (90%).
  • Only 26% of pregnant women received at least one vaccine dose during pregnancy.
  • Lower uptake observed in younger, deprived women, and those in specific French regions.

Conclusions:

  • National recommendations positively influenced vaccination dynamics.
  • Vaccination predominantly occurred outside pregnancy trimesters, with the second trimester being the most common period during pregnancy.
  • Targeted campaigns are recommended to enhance vaccine coverage in pregnant populations.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
43.3K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
763
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
61
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
1.5K